Phase IIIB Extension Clinical Trial of Efficacy and Safety of GST-HG141 (Nairevir) Combined With NAs in Chronic Hepatitis B

NCT07588009 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

576

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis b

Interventions

DRUG: GST-HG141

Sponsor

Fujian Akeylink Biotechnology Co., Ltd.